Ensysce Biosciences, Inc. Quarterly Operating Lease, Payments in USD from Q1 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Ensysce Biosciences, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2022 to Q1 2024.
  • Ensysce Biosciences, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $22.7K, a 18.9% increase year-over-year.
  • Ensysce Biosciences, Inc. annual Operating Lease, Payments for 2023 was $31.2K, a 14.4% increase from 2022.
  • Ensysce Biosciences, Inc. annual Operating Lease, Payments for 2022 was $27.3K, a 9.82% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $22.7K +$3.61K +18.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $19.1K +$1.4K +7.93% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $17.7K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.